Cartesian Therapeutics (RNAC) News Today → If you have $2,500 bucks… check this out (From DTI) (Ad) Free RNAC Stock Alerts $21.03 +0.13 (+0.62%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLeerink Partnrs Weighs in on Cartesian Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:RNAC)americanbankingnews.com - April 26 at 1:26 AMQ1 2024 Earnings Estimate for Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Issued By HC Wainwrightamericanbankingnews.com - April 26 at 1:26 AMCartesian Therapeutics, Inc. (NASDAQ:RNAC) to Post Q1 2024 Earnings of ($0.27) Per Share, HC Wainwright Forecastsmarketbeat.com - April 25 at 7:23 AMLeerink Partnrs Weighs in on Cartesian Therapeutics, Inc.'s FY2027 Earnings (NASDAQ:RNAC)americanbankingnews.com - April 25 at 4:18 AMLeerink Partnrs Reiterates "Outperform" Rating for Cartesian Therapeutics (NASDAQ:RNAC)americanbankingnews.com - April 25 at 3:37 AMEquities Analysts Issue Forecasts for Cartesian Therapeutics, Inc.'s Q1 2025 Earnings (NASDAQ:RNAC)americanbankingnews.com - April 25 at 2:58 AMFY2027 Earnings Forecast for Cartesian Therapeutics, Inc. Issued By Leerink Partnrs (NASDAQ:RNAC)marketbeat.com - April 24 at 6:50 AMLeerink Partnrs Reiterates Outperform Rating for Cartesian Therapeutics (NASDAQ:RNAC)marketbeat.com - April 24 at 5:55 AMCartesian Therapeutics (NASDAQ:RNAC) Now Covered by Analysts at SVB Leerinkamericanbankingnews.com - April 24 at 4:44 AMCartesian Therapeutics (NASDAQ:RNAC) Price Target Increased to $54.00 by Analysts at HC Wainwrightamericanbankingnews.com - April 24 at 4:44 AMBuy Rating Affirmed for Cartesian Therapeutics: Promising CAR-T Therapy and Strategic Financial Movesmarkets.businessinsider.com - April 23 at 2:52 PMCartesian Therapeutics (NASDAQ:RNAC) Price Target Raised to $54.00 at HC Wainwrightmarketbeat.com - April 23 at 7:15 AMCartesian Therapeutics to Present at the ASGCT 27th Annual Meetingbusinesswire.com - April 22 at 4:30 PMMarinus Pharmaceuticals, Cartesian Therapeutics, Adial Pharmaceuticals among healthcare moversmsn.com - April 15 at 10:51 AMCartesian Therapeutics, Inc. (NASDAQ:RNAC) Short Interest Updatemarketbeat.com - April 10 at 8:58 PMCartesian Therapeutics (NASDAQ:RNAC) Sets New 1-Year Low at $13.19marketbeat.com - April 5 at 12:21 PMmarketbeat.com - April 5 at 6:02 AMCartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conferencebusinesswire.com - April 4 at 7:30 AMCartesian Therapeutics Announces New Employment Inducement Grantsbusinesswire.com - April 4 at 7:00 AMShort Interest in Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Expands By 27.3%marketbeat.com - April 1 at 8:31 AMCartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Splitglobenewswire.com - March 28 at 4:05 PMInsider Buying: Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Director Buys 19,044 Shares of Stockinsidertrades.com - March 21 at 10:47 AMCartesian Therapeutics Director Acquires 3.2% More Stockfinance.yahoo.com - March 21 at 9:00 AMCartesian Therapeutics, Inc. (NASDAQ:RNAC) Director Buys $11,426.40 in Stockmarketbeat.com - March 20 at 8:13 PMTimothy A. Springer Purchases 648,372 Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Stockinsidertrades.com - March 19 at 5:00 AMBuy Rating Affirmed for Cartesian Therapeutics: Neutral Impact of Xork Termination and High Hopes for Descartes-08 Trialmarkets.businessinsider.com - March 18 at 11:18 PMCartesian Therapeutics, Inc. (NASDAQ:RNAC) Director Timothy A. Springer Purchases 648,372 Sharesmarketbeat.com - March 18 at 8:04 PMBuy Rating Affirmed for Cartesian Therapeutics Amidst Strong Financial Position and Promising Descartes-08 Clinical Trialsmarkets.businessinsider.com - March 11 at 3:44 PMCartesian Therapeutics, Inc.: Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updatefinanznachrichten.de - March 7 at 10:10 AMCartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updateglobenewswire.com - March 7 at 7:00 AMCartesian Therapeutics, Inc.: Cartesian Therapeutics Announces New Employment Inducement Grantfinanznachrichten.de - March 6 at 5:59 PMBiotech moving HQ outside of Montgomery County following mergerbizjournals.com - March 6 at 5:59 PMCartesian Therapeutics, Inc. Forecasted to Post FY2023 Earnings of ($0.02) Per Share (NASDAQ:RNAC)marketbeat.com - March 6 at 7:31 AMCartesian Therapeutics to Participate in Upcoming Investor Conferencesglobenewswire.com - March 6 at 7:00 AMCartesian Therapeutics Establishes New Corporate Headquarters and State-of-the-Art mRNA Cell Therapy cGMP Manufacturing Facility in Frederick, Marylandfinance.yahoo.com - March 5 at 7:12 AMCartesian Therapeutics Announces New Employment Inducement Grantglobenewswire.com - March 5 at 7:05 AMCartesian Therapeutics Establishes New Corporate Headquarters and State-of-the-Art mRNA Cell Therapy cGMP Manufacturing Facility in Frederick, Marylandglobenewswire.com - March 5 at 7:00 AMCartesian Therapeutics, Inc. (RNAC)finance.yahoo.com - February 16 at 3:43 AMCartesian Therapeutics, Inc.'s (NASDAQ:RNAC) market cap rose US$14m last week; retail investors who hold 50% profited and so did insidersfinance.yahoo.com - February 15 at 9:57 AMCartesian Therapeutics, Inc.: Cartesian Therapeutics Announces New Employment Inducement Grantsfinanznachrichten.de - February 7 at 3:20 AMCartesian Therapeutics Announces New Employment Inducement Grantsfinance.yahoo.com - February 5 at 8:08 PMCartesian Therapeutics Inc.barrons.com - January 22 at 5:12 PMCartesian Therapeutics, Inc. Common Stock (RNAC)nasdaq.com - January 1 at 1:04 PM Get Cartesian Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RNAC and its competitors with MarketBeat's FREE daily newsletter. Email Address The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him RNAC Media Mentions By Week RNAC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RNAC News Sentiment▼0.740.32▲Average Medical News Sentiment RNAC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RNAC Articles This Week▼293▲RNAC Articles Average Week Get Cartesian Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RNAC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RLMD News Today NVCT News Today SCTL News Today ELYM News Today IMUX News Today RPTX News Today CTMX News Today AMLX News Today PDSB News Today RZLT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RNAC) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cartesian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
